Professor | Xin Yi | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xin Yi
Contact Information	yixin321624@126.com
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Xin Yi

Contact Information

yixin321624@126.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2005-2010 Bachelor of Clinical Medicine: Chengde Medical College 2010-2015 PhD in Internal Medicine: Wuhan University First Clinical College 2013-2015 Joint PhD Training: Texas A&M Health Science Center, USA Hosted 8 research projects including National Natural Science Foundation of China
Work Experience	2015.07-2015.11 Resident Physician, Cardiovascular Department, Renmin Hospital of Wuhan University 2015.11-2017.11 Attending Physician, Cardiovascular Department, Renmin Hospital of Wuhan University 2017.11-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital of Wuhan University 2023.05-present Associate Professor, Cardiovascular Department, Renmin Hospital of Wuhan University

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2005-2010 Bachelor of Clinical Medicine: Chengde Medical College
2010-2015 PhD in Internal Medicine: Wuhan University First Clinical College
2013-2015 Joint PhD Training: Texas A&M Health Science Center, USA
Hosted 8 research projects including National Natural Science Foundation of China

Work Experience

2015.07-2015.11 Resident Physician, Cardiovascular Department, Renmin Hospital of Wuhan University
2015.11-2017.11 Attending Physician, Cardiovascular Department, Renmin Hospital of Wuhan University
2017.11-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital of Wuhan University
2023.05-present Associate Professor, Cardiovascular Department, Renmin Hospital of Wuhan University

Areas of Focus	Cardiac remodeling and epigenetic regulation Myocardial ischemia reperfusion injury and epigenetic regulation
Publications	Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation, Yi X, Fang ZM, Zhang SM, Luo H, Jiang DS, Huo B, Zhong X, Feng X, Cheng W, Chen Y, Feng G, Wu X, Zhao F, 2022 Data-independent acquisition proteomics reveals circulating biomarkers of coronary chronic total occlusion in humans, Yi X, Li J, Jiang XJ, Wang QH, Wu XL, Qu Z, Song T, Wan WG, Zheng XX, 2022 BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection, Yi X, Chen Y, Huo B, He Y, Guo X, Zhang Z, Zhong X, Feng X, Fang ZM, Zhu XH, Wei X, Jiang DS, 2022 The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection, Yi X, Zhou Y, Chen Y, Feng X, Liu C, Jiang D-S, Geng J, Li X, Jiang X, Fang Z-M, 2021 Posttranslational Modifications in Ferroptosis, Yi X, Wei X, Zhu XH, Jiang DS, 2020 Histone methylation and vascular biology, Yi X, Wei X, Zhu XH, Jiang DS, 2020 Histone methyltransferase SMYD2: ubiquitous regulator of disease, Yi X, Jiang XJ, Fang ZM, 2019 EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection, Yi X, Li R, Wei X, Huo B, Guo X, Cheng C, Fang ZM, Wang J, Feng X, Zheng P, Su YS, Masau JF, Zhu XH, Jiang DS, 2018 Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts, Yi X, Tao Y, Lin X, Dai Y, Yang T, Yue X, Jiang X, Li X, Jiang DS, Andrade KC, Chang J, 2017

Areas of Focus

Cardiac remodeling and epigenetic regulation
Myocardial ischemia reperfusion injury and epigenetic regulation

Publications

Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation, Yi X, Fang ZM, Zhang SM, Luo H, Jiang DS, Huo B, Zhong X, Feng X, Cheng W, Chen Y, Feng G, Wu X, Zhao F, 2022
Data-independent acquisition proteomics reveals circulating biomarkers of coronary chronic total occlusion in humans, Yi X, Li J, Jiang XJ, Wang QH, Wu XL, Qu Z, Song T, Wan WG, Zheng XX, 2022
BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection, Yi X, Chen Y, Huo B, He Y, Guo X, Zhang Z, Zhong X, Feng X, Fang ZM, Zhu XH, Wei X, Jiang DS, 2022
The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection, Yi X, Zhou Y, Chen Y, Feng X, Liu C, Jiang D-S, Geng J, Li X, Jiang X, Fang Z-M, 2021
Posttranslational Modifications in Ferroptosis, Yi X, Wei X, Zhu XH, Jiang DS, 2020
Histone methylation and vascular biology, Yi X, Wei X, Zhu XH, Jiang DS, 2020
Histone methyltransferase SMYD2: ubiquitous regulator of disease, Yi X, Jiang XJ, Fang ZM, 2019
EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection, Yi X, Li R, Wei X, Huo B, Guo X, Cheng C, Fang ZM, Wang J, Feng X, Zheng P, Su YS, Masau JF, Zhu XH, Jiang DS, 2018
Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts, Yi X, Tao Y, Lin X, Dai Y, Yang T, Yue X, Jiang X, Li X, Jiang DS, Andrade KC, Chang J, 2017

Cardiac Remodeling Epigenetics Gene Regulation Cardiovascular Diseases Myocardial Ischemia Reperfusion Injury Molecular Biology Cellular Mechanisms Gene Expression Therapeutic Targets

Wei Deng - Wuhan University

Zheng Yang - Wuhan University

Yangpo Cao - Southern University of Science and Technology

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us